Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1389557521666210210160237 http://scihub22266oqcxt.onion/10.2174/1389557521666210210160237 33568033!ä!33568033 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mini+Rev+Med+Chem 2021 ; 21 (16): 2204-2208 Nephropedia Template TP {{tp|p=33568033|t=2021. Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) |pdf=|usr=}}{{33568033}} gab.com Text Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) JO: Mini Rev Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=33568033 #FOAvip COVID-19 is an emerging viral infection of zoonotic origin that is closely related to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused an outbreak in 2003. Therefore, scientists named the new virus SARS-CoV-2. On March 11, 2020, The World Health Organization (WHO) recognized COVID-19 as a global pandemic. At present, three vaccines have been approved or are being considered for approval by national regulatory agencies to immunize against COVID- 19. However, the vaccines do not remain widely available, and no specific treatment against the virus is available. The pathogenesis and proliferation pathways of SARS-CoV-2 are still not well known. Thus, in this article, the saponin glycyrrhizin is discussed as a new potential therapeutic agent of natural origin (licorice root, Glycyrrhiza glabra) for the potential treatment of COVID-19 infections. Twit Text FOAVip Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) ????Mini Rev Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=33568033 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33568033 #FOAvip English Wikipedia <ref>{{Cite pmid|33568033}}</ref> Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) #MMPMID33568033 Al-Kamel H; Grundmann O Mini Rev Med Chem 2021[]; 21 (16): 2204-2208 PMID33568033show ga COVID-19 is an emerging viral infection of zoonotic origin that is closely related to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused an outbreak in 2003. Therefore, scientists named the new virus SARS-CoV-2. On March 11, 2020, The World Health Organization (WHO) recognized COVID-19 as a global pandemic. At present, three vaccines have been approved or are being considered for approval by national regulatory agencies to immunize against COVID- 19. However, the vaccines do not remain widely available, and no specific treatment against the virus is available. The pathogenesis and proliferation pathways of SARS-CoV-2 are still not well known. Thus, in this article, the saponin glycyrrhizin is discussed as a new potential therapeutic agent of natural origin (licorice root, Glycyrrhiza glabra) for the potential treatment of COVID-19 infections. |*COVID-19 Drug Treatment[MESH] |COVID-19/virology[MESH] |Glycyrrhizic Acid/*pharmacology/*therapeutic use[MESH] |Humans[MESH]Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID(epmc).pdf DeepDyve Pubget Overpricing